Tupaia aggregates and visualises data from multiple sources to help improve medicines availability, map disease outbreaks, respond to disasters and strengthen service provision in the Indo-Pacific.

The Tropical Disease Research Regional Collaboration Initiative: Responding to Drug-Resistant Tuberculosis and Malaria in the Asia-Pacific aims to strengthen health systems and research capacity, including high-quality operational research to prevent and contain malaria and TB.

The PRIME-TB project aims to establish four knowledge hubs that can pilot and scale up successful innovations in TB case detection and models of care, and conduct enhanced molecular and epidemiological surveillance, supporting the micro-elimination of TB in these areas.

Through the mSupply open project, open source software will be made available for installation that will facilitate medical product registration and stock management of medical products across health system levels.

Through a scholarship program, national regulatory authority staff will complete postgraduate level courses from the Graduate Certificate in Health Products Regulation program at Duke-National University of Singapore.

The national drug quality laboratories of Cambodia and Laos will be strengthened to international laboratory standards with the necessary capacity and functionality to conduct drug quality testing.

Australia’s Therapeutic Goods Administration is working with key Indo-Pacific counterparts to improve their regulatory systems and processes, including through sharing regulatory information.

The Innovative Vector Control Consortium (IVCC) develops new insecticides for vector control by focusing resources and targeting practical scientific solutions.

Medicines for Malaria Venture (MMV) is recognized as the leading product development partnership in the field of antimalarial drug research and development.

FIND, the global alliance for diagnostics, is an international non-profit organization that enables the development and delivery of much-needed diagnostic tests for poverty-related diseases.